Gulf Breeze, FL, Dec. 06, 2024 (GLOBE NEWSWIRE) -- Limitless Biotech, a leading innovator in sexual health solutions, is thrilled to announce the release of its groundbreaking PT-141 nasal spray, a ...
Yuka Group, Inc. is a holding company, which operates through its fully owned subsidiary. Its products include Testosterone Replacement Therapy, Platelet Rich Plasma Injections, PT-141 Peptide Therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results